3D QSAR studies of N-4-arylacryloylpiperazin-1-yl-phenyl-oxazolidinones: A novel class of antibacterial agents

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 14, 2006, Pages 3817-3823

  Lohray, B B ^a   Gandhi, Neha ^a   Srivastava, Brijesh Kumar ^a   Lohray, Vidya Bhushan ^a  

^a ZYDUS RESEARCH CENTRE   (India)

Author keywords

3D QSAR; Antibacterial agent; Arylacryloylpiperazinylphenyloxazolidinones; Heat of formation; In vitro MIC; LUMO

Indexed keywords

ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG STRUCTURE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING;

ANTI-BACTERIAL AGENTS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; PIPERAZINES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; STAPHYLOCOCCUS AUREUS;

STAPHYLOCOCCUS AUREUS;

EID: 33746758901     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.04.023     Document Type: Article

References (24)

1. Service R.F. Science 270 (1995) 724
2. Swaney S.M., Aoki H., Ganoza M.C., and Shinabarger D.L. Antimicrob. Agents Chemother. 42 (1998) 3251
3. Brickner S.J. Curr. Pharm. Des. 2 (1996) 175
4. Plosker G.L., and Figgitt D.P. Pharmacoeconomics 23 (2005) 945
5. Pae A.N., Kim S.Y., Kim H.Y., Joo H.J., Cho Y.S., Choi K.I., Choi J.H., and Koh H.Y. Bioorg. Med. Chem. Lett. 9 (1999) 2685
6. Karki R.G., and Kulkarni V.M. Bioorg. Med. Chem. 9 (2001) 3153
7. Gopalakrishnan B., Khandelwal A., Rajjak S.A., Selvakumar N., Das J., Trehan S., Iqbal J., and Kumar M.S. Bioorg. Med. Chem. 11 (2003) 2569
8. Katritzky A.R., Fara D.C., and Karelson M. Bioorg. Med. Chem. 12 (2004) 3027
9. Tokuyama R., Takahashi Y., Tomita Y., Tsubouchi M., Yoshida T., Iwasaki N., Kado N., Okezaki E., and Nagata O. Chem. Pharm. Bull. 49 (2001) 353
10. Sztanke K., Pasternak K., and Sztanke M. Ann. Univ. Mariae Curie Sklodowska 59 (2004) 335
11. Phillips O.A. Curr. Opin. Investig. Drugs 6 (2005) 768
12. Gravestock M.B.. Curr. Opin. Drug Discov. Devel. 8 (2005) 469
13. Bozdogan B., and Appelbaum P.C. Int. J. Antimicrob. Agents 23 (2004) 113
14. Hutchinson D.K. Curr. Top. Med. Chem. 3 (2003) 1021
15. Nilius A.M. Curr. Opin. Investig. Drug 4 (2003) 149
16. Lohray, B. B.; Lohray, V. B.; Srivastava, B. K. WO03/082864, 2003.
17. Mehta, A.; Arora, S. K.; Biswajit, D.; Ray, A.; Rudra, S.; Rattan, A. WO03/007870, 2003.
18. Natsan, S.; Jagattaran, D.; Iqbal, J.; Magadi, S. K.; Naga, S. R.; Mamidi, V.; Ramanujam, R.; Sundarababu, B.; Lohray, B. B. US Patent Appl. 03/0065175, 2003.
19. Lohray V.B., Lohray B.B., and Srivastava B.K. Pure Appl. Chem. 77 (2005) 195
20. Srivastava B.K., Kapadnis P.B., Pandya P., and Lohray V.B. Eur. J. Med. Chem. 39 (2004) 989
21. Lohray B.B., Lohray V.B., Srivastava B.K., Gupta S., Solanki M., Kapadnis P., Takale V., and Pandya P. Bioorg. Med. Chem. Lett. 14 (2004) 3139
22. Lohray, B. B.; Lohray, V. B.; Srivastava, B. K.; Gupta, S.; Solanki, M.; Jayadev. S. R. Substituted oxazolidinones as novel antibacterial agents. Manuscript in preparation.
23. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; 4th ed. (Approved Standard); NCCLS Document M7-A4; NCCLS: Wayne, PA, 1997.
24. TSAR 3.3 Reference Guide, Oxford Molecular Limited, 2000.